Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
Our understanding of fatty liver syndromes and their relationship with the metabolic syndrome has improved over recent decades and, paralleling this, we are now at the dawn of the NAFLD (nonalcoholic fatty liver disease) to MAFLD (metabolic-associated fatty liver disease) transition. The pitfalls of...
Main Author: | Amedeo Lonardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/3/492 |
Similar Items
-
NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III
by: Qi Huang, et al.
Published: (2021-07-01) -
From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
by: Marta Flisiak-Jackiewicz, et al.
Published: (2021-03-01) -
Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
by: Ilaria Barchetta, et al.
Published: (2020-10-01) -
Role of Insulin Resistance in MAFLD
by: Yoshitaka Sakurai, et al.
Published: (2021-04-01) -
Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
by: Yen-Po Lin, et al.
Published: (2021-07-01)